Lancet 397(10278):971984 Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D et al (2023) Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
For people who prefer oral delivery, Foundayo Pill with Ongoing Care is also available as part of the program
Trans R Soc Trop Med Hyg
Any trial of an alternative GLP-1 agonist should occur under close medical supervision, ideally in a setting where emergency treatment is readily available
For individuals who have attempted diet and exercise modifications without achieving lasting results, GLP-1 medications work through appetite regulation mechanisms that may address underlying biological factors
The incubation time was one hour at 37 C, under continuous agitation at 100 rpm